MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about BIIB

Recent news which mentions BIIB

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
Tickers ABBV AMGN BIIB BMY
Tags Briefs INCY Expert Ideas
From Benzinga
Biogen (BIIB) Q3 2024 Earnings Call Transcript
Tickers BIIB
Tags Recent Press Releases BIIB Market News
From Motley Fool
Biogen's Q3 Profit Beats Expectations On Lower Multiple Sclerosis Revenues But New Products Offset Losses, Raises Profit Outlook
Tickers BIIB NEWS
Tags Guidance Biotech Briefs
From Benzinga
This Setback for Johnson & Johnson Is 1 More Green Light for Eli Lilly's Stock
Tickers BIIB JNJ LLY
Tags Market News JNJ BIIB
From Motley Fool
Looking Into Biogen's Recent Short Interest
Tickers BIIB
Tags Market News BIIB Short Sellers
From Benzinga
After Series Of Trial Setbacks, Sage Therapeutics To Lay Off One-Third Workforce
Tickers BIIB NEWS SAGE
Tags Stories That Matter Top Stories Management
From Benzinga
Larimar Therapeutics' New Drug Could Transform Treatment For Rare Neurological Disease, Analyst Sees Over 200% Upside For Stock
Tickers BIIB LRMR NEWS PTC
Tags Trading Ideas Expert Ideas Analyst Ratings
From Benzinga
Eli Lilly's Alzheimer's Drug Raises Hopes but Faces Regulatory Hurdles in Europe
Tickers BIIB ESALY LLY NEWS
Tags Top Stories Stories That Matter News
From Benzinga
The Latest Analyst Ratings For Biogen
Tickers BIIB
Tags BIIB Analyst Ratings Market News
From Benzinga
After Disappointing Parkinson's Data, Sage Therapeutics' Dalzanemdor Flunks Mid-Stage Alzheimer's Study
Tickers BIIB NEWS SAGE
Tags Health Care alzheimer's SAGE
From Benzinga
Scholar Rock's Muscle Wasting Drug Excels In Pivotal Trial, Plans FDA Submission Next Year
Tickers BIIB NEWS RHHBY SRRK
Tags SRRK Health Care Benzinga
From Benzinga
Looking Into Biogen's Recent Short Interest
Tickers BIIB
Tags Trading Ideas Benzinga BIIB
From Benzinga
1 Unstoppable Growth Stock Heading to $2 Trillion by 2030
Tickers BIIB LLY
Tags Market News BIIB LLY
From Motley Fool
Biogen Terminates Collaboration With Sage Therapeutics For Neurological Disorder Candidate
Tickers BIIB NEWS SAGE
Tags SAGE Benzinga Health Care
From Benzinga
Biogen/UCB Partnered Autoimmune Disease Candidate Hits Primary Goal In Late-Stage Study, Sets Stage Another Pivotal Trial
Tickers BIIB NEWS UCBJF UCBJY
Tags BIIB UCBJY Market News
From Benzinga
Forecasting The Future: 20 Analyst Projections For Biogen
Tickers BIIB
Tags BZI/AAR Benzinga BIIB
From Benzinga
Zepbound And Mounjaro Maker Eli Illy Has A New CFO As It Navigates Regulatory Challenges: What You Should Know
Tickers BIIB LLY NEWS NVDA
Tags Global Kaustubh Bagalkote Benzinga
From Benzinga
Bernie Sanders Says If You're Poor In America You'll Live 10-15 Years Less: 'Anybody Else See A Problem With That?'
Tickers BIIB BMY NEWS
Tags Market News Vermont Shivdeep Dhaliwal
From Benzinga
Biogen/Eisai's Leqembi Brings Hope To Early Alzheimer's Patients Amid Logistical Challenges
Tickers BIIB ESALY NEWS
Tags Market News BIIB Stories That Matter
From Benzinga
Biogen's Higher Dose Spinraza Shows To Slow Neurodegeneration Faster In Infants With Rare Neuromuscular Disorder
Tickers BIIB NEWS
Tags Top Stories Stories That Matter General
From Benzinga
Key Takeaways From Biogen Analyst Ratings
Tickers BIIB
Tags Benzinga BZI/AAR BIIB
From Benzinga
These 3 Factors Could Make Eli Lilly Stock a Better Buy Than Novo Nordisk Right Now
Tickers BIIB LLY NVO
Tags LLY Recent Press Releases NVO
From Motley Fool
Eli Lilly Is The Nvidia Of Weight Loss And GLP-1 Space, Says Roundhill Investments CEO, Emphasizes Market Leadership And Growth Potential Of Zepbound Maker
Tickers BIIB LLY NEWS NVDA
Tags Markets Benzinga Kaustubh Bagalkote
From Benzinga
Chinese E-Commerce Giant Drops 35% In 2 Days, But Analysts See 92% Upside Potential
Tickers ASIA BIIB DCOM DLTR
Tags Large Cap DCOM China
From Benzinga
Eli Lilly's Alzheimer's Drug Faces UK Agency Block After Biogen's Medicine Rejection Over Cost, Safety
Tickers BIIB LLY NEWS
Tags Briefs Biotech BIIB
From Benzinga
Biogen's Alzheimer's Drug Secures UK Approval, But An Independent Agency Does Not Recommend Reimbursement
Tickers BIIB ESAIY ESALF NEWS
Tags ESAIY BIIB Market News
From Benzinga
Cracking The Code: Understanding Analyst Reviews For Biogen
Tickers BIIB
Tags BZI/AAR Benzinga Analyst Ratings
From Benzinga
A Blood Test Could Detect Early Alzheimer's. That Could Make These 2 Stocks Red-Hot Buys.
Tickers BIIB LLY
Tags ESAI/Y Recent Press Releases LLY
From Motley Fool
How Is The Market Feeling About Biogen?
Tickers BIIB
Tags Short Sellers BZI/SHORTHIST Short Ideas
From Benzinga
Biogen (BIIB) Q2 2024 Earnings Call Transcript
Tickers BIIB
Tags Recent Press Releases Market News BIIB
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story